1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow pegilodecakin: new trials by email Literature Review of pegilodecakin trials Research Report on pegilodecakin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer Pegilodecakin, FOLFOX - Pancreatic Cancer | Phase 3 | Completed | Eli Lilly and Company | 567 | 2017-03-01 | 2020-10-19 |
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)
2016 (1)